‡øëHŠÊ˜·³Ç Manifesto for Investment, Health and Growth

The innovative pharmaceutical industry has the potential to drive the health and wealth of the UK. It already makes a significant contribution to UK research and development (R&D) investment, worth around £5 billion in 2020.1 The medicines and vaccines our industry develops are transformative for public health, patients and the NHS.
This manifesto sets out the ‡øëHŠÊ˜·³Ç’s vision for how the UK can overtake its global competitors. Implementing these proposals will create a virtuous cycle, where investment in medicines and research accelerates future waves of innovation and attracts an increased UK share of global R&D.
Delivering these proposals requires a true partnership between industry and government, centred on the principles of collaboration, transparency of delivery, and a unified approach to health and growth.
1. Life science competitiveness indicators 2022 – GOV.UK (www.gov.uk).
- ‡øëHŠÊ˜·³Ç Manifesto
Last modified: 19 June 2024
Last reviewed: 19 June 2024